March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

March 02, 2026

Machine Learning May Help Refine Fracture Risk Prediction

"Machine learning should be used to identify postmenopausal women at increased risk of fractures."

Conexiant

February 25, 2026

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

Conexiant

February 24, 2026

Can CT Radiomics Detect Osteoporosis?

Radiomics analysis of lumbar spine computed tomography is compared with established imaging-based measures of bone density.

Conexiant

February 23, 2026

Sleep Disruption and Osteoarthritis Risk

Investigators find that short sleep, insomnia, and night shift work are associated with increased risk of knee and hip osteoarthritis and joint replacement.

Conexiant

February 16, 2026

Shoulder MRI: Rethinking Findings

Routine imaging may detect age-related tendon changes that do not explain patient-reported shoulder pain.

Conexiant

February 13, 2026

Primary Care’s Rug Pulled Out?

CMS abruptly scraps a 10-year primary care model, leaving nearly 700 practices rethinking staffing, funding, and patient access.

KFF Health News

February 13, 2026

Torsional Deformity Masquerading as Knee Instability

Persistent knee pain and gait disturbance exposed an overlooked lower extremity diagnosis.

Conexiant

February 12, 2026

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

Conexiant